Literature DB >> 2904564

Pelvic irradiation and tamoxifen as risk factors for carcinoma of corpus uteri.

L Hardell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2904564     DOI： 10.1016/s0140-6736(88)90629-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  The 4Ps of Breast Cancer Chemoprevention: Putting Proven Principles into Practice.

Authors:  V Craig Jordan
Journal:  Cancer Prev Res (Phila)       Date:  2017-02-28

Review 2.  Long-term adjuvant tamoxifen therapy for breast cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

Review 3.  Historical review of the causes of cancer.

Authors:  Clarke Brian Blackadar
Journal:  World J Clin Oncol       Date:  2016-02-10

4.  The effect of tamoxifen on the endometrium.

Authors:  B Uziely; A Lewin; G Brufman; D Dorembus; S Mor-Yosef
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 5.  What do we know and what don't we know about tamoxifen in the human uterus.

Authors:  A Friedl; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  The prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based study.

Authors:  Chien-Tung Wu; Jung-Nien Lai; Yueh-Ting Tsai
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.